Register

benefits

The Obesity Therapies Europe 2027 forum brings together the teams closing the gap between fast-moving obesity therapeutics and the market access pathways needed to reach patients.

Benefits of attending include:

  • Two days of focused presentations on sustaining durable, muscle-sparing weight loss, and next-generation dosing strategies across European obesity therapy programmes.
  • A meeting ground for teams expanding obesity therapies beyond weight loss, from amylin agonists to triple agonists, opening new indications across Europe.
  • Benchmark your pricing strategy against peers already navigating the shift to oral, small-molecule obesity therapeutics.
  • Walk away with a Joint Clinical Assessment readiness plan your team can act on immediately.
  • Learn how commercial teams are defending brand value ahead of biosimilar entry, before it reaches your own portfolio.
  • Identify the new patient populations and revenue channels opening as out-of-pocket demand converts to reimbursed access.

view program

key takeaways

  • Build a maintenance-dosing strategy that keeps weight off without sacrificing the muscle and bone health your patients need long term.
  • Map where amylin and triple agonists are likely to open new indications next, and what that means for your pipeline.
  • Model the pricing and manufacturing trade-offs between small-molecule oral therapies and injectable peptides before you must defend them internally.
  • Translate NICE, G-BA, HAS and AIFA requirements into a single Joint Clinical Assessment-ready submission.
  • Anticipate how biosimilar entry will reshape tendering and pricing in your markets, and what commercial defence looks like in practice.

who should attend?

This gathering brings together Europe’s obesity commercial and access leaders, spanning market access, health economics, medical affairs, and payer relations to navigate the region's next therapeutic wave.

From the following industry sectors:

Academic Medical Centres Health Ministries and Authorities Obesity-Focused CROs Amylin and Triple Agonist Biotechs Hospital Pharmacy Networks Patient Adherence Programmes Auto-Injector and Device Makers HTA and Pricing Consultancies Patient Advocacy Organisations Biosimilar & Follow-On Developers Integrated Care Networks Private Health Insurers Compounding Pharmacies Market Access Consultancies Real-World Evidence Providers Digital Weight-Loss Platforms National HTA Bodies Retail and Online Pharmacy Chains Employer Benefit Managers Obesity Clinical Trial Networks Statutory Sickness Funds GLP-1 and Incretin Manufacturers Obesity Management Centres Telehealth Prescribing Platforms

Core attendees include CEOs, COOs, CFOs, Presidents, Vice Presidents, Directors, Heads of, Superintendents, and Managers involved in:

Chief Executive Officers Director, Outcomes Research VP, Government Affairs Chief Financial Officers Director, Real-World Evidence VP, Health Economics Chief Hospital Pharmacists Head of Key Accounts VP, Market Access Europe Chief Operating Officers Head of Payer Relations VP, Medical Affairs Chief Scientific Officers Head of Value and Access VP, Obesity Franchise Director, Biosimilar Strategy Head of Health Policy VP, Patient Access Director, Formulary Strategy Senior Medical Science Liaison VP, Pricing and Reimbursement Director, HTA Strategy VP, Business Development VP, Regulatory Affairs

they've attended our events

Danielle Cunha

Fiocruz

"Engaging event with clear, direct talks and plenty of opportunity to network and exchange ideas."

Markus von Minden

EY-Parthenon

"A great conference bringing together startups, biotech companies, and CDMOs in one room."

Ananya Ray Soni

Novo Nordisk

"An insightful conference covering key topics in a compact, focused format."

Kavneet Pujji

Kindeva Drug Delivery

"A valuable introduction to the latest developments in drug delivery systems"

Shabnam Mohandessi

Corden Pharma

"I valued the diversity of attendees, bringing perspectives from across different sectors."

Fabrice Gritti

Waters Corporation

"The format is ideal for focused, meaningful interactions."

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.